CompletedN/Aketamine

The Postoperative Lidocaine and Ketamine Effects on Morphine Requirement in Bariatric Surgery

Sponsored by Tiva Group

NCT ID
NCT05591105
Target Enrollment
64 participants
Start Date
2023-06-15
Est. Completion
2024-01-31

About This Study

The goal of this observational study is to evaluate the quality of postoperative analgesia in a group of obese patients schedule to bariatric surgery under TIVA Opiod-free after to receive lidocaine and ketamine perfusion. The main question it aims to answer are: How lidocaine and ketamine perfusion during recovery period does impact over morphine consumption on the following 48 hours after surgery? All participants will receive total intravenous anesthesia and, at the end of the surgery, they will be divided in two groups, group A: placebo and, group B: with postoperative lidocaine and ketamine perfusion. Our hypothesis is ketamine and lidocaine are a good alternative to decrease the use of morphine in obese patients.

Conditions Studied

Pharmacological ActionPost Operative PainOpioid UseObesity, MorbidAnesthesia Morbidity

Interventions

  • Control Group
  • Placebo

Eligibility

Age:18 Years - 65 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* All patients between 18 y 65 years old.
* IMC \> 30 kg/m2
* ASA II/III

Exclusion Criteria:

* Patients taking high doses of opioids before operation for chronic pain
* Patients with allergies to any study medication.
* Pregnancy or breastfeeding.
* Kidney or heptic failure.
* Surgical complication

Study Locations (1)

Carolina
Barcelona, Spain

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

The Postoperative Lidocaine and Ketamine Effects on Morphine Requirement in Bariatric Surgery | Huxley